Literature DB >> 24082756

Juvenile osteoporosis in a 5-year-old girl.

Saket R Sanghai1, Ira Shah.   

Abstract

Idiopathic juvenile osteoporosis (IJO) is a term used to describe a primary osteoporosis of unknown etiology in prepubertal children. It is rarely described in the literature and treatment modalities vary with spontaneous remission also being reported at the time of puberty. We report a 5-year-old girl with IJO who had spinal deformities and was successfully treated with oral alendronate.

Entities:  

Keywords:  Alendronate; children; juvenile osteoporosis

Year:  2013        PMID： 24082756      PMCID： PMC3783804          DOI： 10.4103/0976-9668.116979

Source DB:  PubMed          Journal:  J Nat Sci Biol Med        ISSN： 0976-9668


  7 in total

1.  Juvenile idiopathic osteoporosis.

Authors:  M L Kulkarni; K S Keshavamurthy
Journal:  Indian Pediatr       Date:  2004-07       Impact factor: 1.411

2.  Juvenile osteoporosis: bone findings in seven patients.

Authors:  J Jowsey; K A Johnson
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

3.  Osteoporosis in childhood.

Authors:  C E Dent
Journal:  Postgrad Med J       Date:  1977-08       Impact factor: 2.401

4.  Idiopathic juvenile osteoporosis.

Authors:  G E Krassas
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.

Authors:  Linda A DiMeglio; Munro Peacock
Journal:  J Bone Miner Res       Date:  2005-10-17       Impact factor: 6.741

6.  Idiopathic osteoporosis in the young.

Authors:  R Smith
Journal:  J Bone Joint Surg Br       Date:  1980-11

7.  The bone formation defect in idiopathic juvenile osteoporosis is surface-specific.

Authors:  F Rauch; R Travers; M E Norman; A Taylor; A M Parfitt; F H Glorieux
Journal:  Bone       Date:  2002-07       Impact factor: 4.398
  7 in total
  1 in total

Review 1.  Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.

Authors:  Stefania Costi; Teresa Giani; Francesco Orsini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2022-01-11       Impact factor: 3.022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.